Medios AG Adjusts 2026 Financial Guidance

Medios AG has revised its financial outlook for 2026. For the first time, the company achieved over €1 billion in group revenue in the first half, totaling approximately €1,075 million, compared to €991.7 million in H1 2025. Despite this growth, EBITDA pre¹ fell slightly to about €44 million, down from €46.3 million the previous year. Consequently, the full-year 2026 EBITDA pre¹ is now expected between €88 million and €92 million, revising the previous projection of €94 to €102 million. Meanwhile, revenue guidance has increased from an earlier estimate of €2.0 to €2.12 billion to now €2.1 to €2.16 billion.

The decline in earnings is attributed to persistent price pressures in the Pharmaceutical Supply segment and restricted reimbursement in the medical cannabis sector due to legislative changes, alongside weaker performance in international business. The company is intensifying cost-reduction and efficiency initiatives in response. The Half-Year Financial Report will be released on August 12, 2026.